Jim Simons Night Hawk Biosciences, Inc. Call Options Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NHWK
# of Institutions
32Shares Held
2.21MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY397KShares$63,4710.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA364KShares$58,1950.0% of portfolio
-
Warberg Asset Management LLC Winnetka, IL283KShares$45,2860.32% of portfolio
-
Geode Capital Management, LLC Boston, MA211KShares$33,8370.0% of portfolio
-
Ubs Group Ag164KShares$26,1730.0% of portfolio
About NightHawk Biosciences, Inc.
- Ticker NHWK
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,661,500
- Market Cap $4.11M
- Description
- NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...